Serological Cytokine and chemokine profile in pregnant women with COVID19 in Mexico City
Cerbulo-Vazquez, A.; Zavala-Barrios, B.; Briones-Garduno, J. C.; Guerrero-Avendano, G. M. L.; Arriaga-Pizano, L.; Ferat-Osorio, E.; Cabrera-Rivera, G. L.; Miranda-Cruz, P.; Garcia de la Rosa, M. T.; Prieto-Chavez, J. L.; Rivero-Arredondo, V.; Madera-Sandoval, R.; Cruz-Cruz, A.; Salazar-Rios, E.; Serrano-Molina, D.; De Lira-Barraza, R.; Villanueva-Compean, A. H.; Esquivel-Pineda, A.; Ramirez-Montes de Oca, R.; Flores-Padilla, G.; Lopez-Macias, C.
Show abstract
On January 30th, 2020, the WHO declared the outbreak of COVID19, a disease due to the new coronavirus called SARS-CoV-2. Certain comorbidities, symptoms and signs are characteristic of COVID19 in the general population and in pregnant women. However, pregnant women are considered as a high-risk group for COVID19. To know about the frequency of comorbidities, signs and symptoms, the presence of lymphopenia, antibodies response to SARS-CoV2 and cytokine and chemokine serum concentration, six pregnant women with COVID19 were studied at the moment of admission. The lower concentration of CCL17 was detected in the Pregnant COVID19 group, similar concentration of IL-6 was also detected in non-pregnant and pregnant COVID19 patients. Our result show that pregnant and non-pregnant women with COVID19 has similar cytokine profile.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- COVID-19 Disease Severity and Determinants among Ethiopian Patients: A study of the Millennium COVID-19 Care Center 96%
- Laboratory Biomarkers of COVID-19 Disease Severity and Outcome: Findings from a Developing Country 96%
- Characteristics and outcome profile of Hospitalized African COVID-19 patients: The Ethiopian Context 96%
Similar papers in this journal
- Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities 97%
- A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender. 95%
- Evaluation of rapid antibody test and chest computed tomography results of COVID-19 patients: A retrospective study 95%
Similar papers in this journal
- Evaluation of the disease outcome in Covid-19 infected patients by disease symptoms: a retrospective cross-sectional study in Ilam Province, Iran 96%
- Determinants of Developing Symptomatic Disease in Ethiopian COVID-19 Patients 96%
- Specific Dynamic Variations in the Peripheral Blood Lymphocyte Subsets in COVID-19 and Severe Influenza A Patients: A Retrospective Observational Study 94%
Similar papers in this journal
- Levels of produced antibodies after vaccination with mRNA vaccine; effect of previous infection with SARS-CoV-2 93%
- Integrative systems biology approach identified crucial genes and transcription factors associated with gallbladder cancer pathogenesis 93%
- Medroxyprogesterone reverses tolerable dose metformin-induced inhibition of invasion via matrix metallopeptidase-9 and transforming growth factor-β1 in KLE endometrial cancer cells 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.